Saved in:
| Main Authors: | Marras, Connie, Arbatti, Lakshmi, Hosamath, Abhishek, Amara, Amy, anderson, karen, Chahine, Lana, Eberly, Shirley, Kinel, Dan, Mantri, Sneha, Mathur, Soania, Oakes, David, Purks, Jennifer, Standaert, David, Tanner, Caroline, Weintraub, Daniel, Shoulson, Ira |
|---|---|
| Format: | Recurso digital |
| Language: | |
| Published: |
Zenodo
2023
|
| Subjects: | |
| Online Access: | https://doi.org/10.3233/JPD-225083 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Association between Subjective Cognitive Complaints and Incident Functional Impairment in Parkinson's Disease
by: Daniel Weintraub, et al.
Published: (2024)
by: Daniel Weintraub, et al.
Published: (2024)
Determining Medication Adherence in Patients Treated for Parkinson’s Disease and Related Factors
by: Mahboobeh Besharatpour, et al.
Published: (2025)
by: Mahboobeh Besharatpour, et al.
Published: (2025)
Predictive Value of Brain Volumetry in the Response to Subthalamotomy Using High‐Intensity Focused Ultrasound Treatment in Patients With Parkinson’s Disease
by: Alfaro-Nasta E., et al.
Published: (2025)
by: Alfaro-Nasta E., et al.
Published: (2025)
Patient‐Reported Outcomes of Rotigotine in Parkinson’s Disease: Real‐World Evidence on Symptom Control and Quality of Life From China
by: Xiaodong Zhu, et al.
Published: (2025)
by: Xiaodong Zhu, et al.
Published: (2025)
Serum GDF‐15 Levels Correlate With Motor and Nonmotor Symptom Domains and Overall Disease Severity in Patients With Parkinson’s Disease
by: Noriyuki Miyaue, et al.
Published: (2026)
by: Noriyuki Miyaue, et al.
Published: (2026)
Preoperative Attention/Memory Problem Affects the Quality of Life of Parkinson’s Disease Patients after Deep Brain Stimulation: A Cohort Study
by: Ying Gao, et al.
Published: (2024)
by: Ying Gao, et al.
Published: (2024)
China’s Modified Version of Sniffin’ Sticks 12‐Identification Test Used in Chinese Parkinson’s Disease and Multiple System Patients: Comparison of Three Olfactory Testing Methods
by: Huijing Liu, et al.
Published: (2024)
by: Huijing Liu, et al.
Published: (2024)
Alteraciones cognitivas en Parkinson Juvenil causado por la mutación C212Y en el gen Parkin.
by: Sonia Moreno
Published: (2010)
by: Sonia Moreno
Published: (2010)
The perception of apathy by caregivers of patients with dementia in Parkinson’s disease
by: Carlos Henrique Ferreira Camargo
Published: (2016)
by: Carlos Henrique Ferreira Camargo
Published: (2016)
A Systematic Review and Meta-Analysis of the Efficacy and Safety of Rasagiline or Pramipexole in the Treatment of Early Parkinson’s Disease
by: Pauli Seppänen, et al.
Published: (2024)
by: Pauli Seppänen, et al.
Published: (2024)
Percepção da qualidade de vida de indivíduos com doença de parkinson através do PDQ-39
by: RC Lana
Published: (2007)
by: RC Lana
Published: (2007)
An Observational Study to Find Impact of Maternal Age at First Pregnancy on Maternal and Perinatal Outcomes
by: International Journal of Medical Science and Innovative Research (IJMSIR)
Published: (2024)
by: International Journal of Medical Science and Innovative Research (IJMSIR)
Published: (2024)
Method of Tremor Levodopa Responsiveness Assessment and Its Correlation With Clinical Factors in Parkinson’s Disease: Outcomes of the Acute Levodopa Challenge Test
by: Fangfei Li, et al.
Published: (2025)
by: Fangfei Li, et al.
Published: (2025)
Daily Fluid Intake in People With Newly Diagnosed Parkinson’s Disease Is Reduced Compared With Controls
by: Isobel J. Sleeman, et al.
Published: (2025)
by: Isobel J. Sleeman, et al.
Published: (2025)
Views and Experiences of Online Exercise Groups for People With Parkinson’s Disease: A Qualitative Study
by: James Alexander, et al.
Published: (2026)
by: James Alexander, et al.
Published: (2026)
ICF‐Based Assessment of Functioning Problems in Parkinson’s Disease: Findings From a Cross‐Sectional Survey in Southern Ghana
by: Mary Wetani Agoriwo, et al.
Published: (2026)
by: Mary Wetani Agoriwo, et al.
Published: (2026)
EMPOWER‐PD: Evaluation of an 8‐Week Co‐Designed Self‐Management Program in People With Parkinson’s Disease and Their Caregivers: An Intervention Study With Long‐Term Follow‐Up
by: Trine Hørmann Thomsen, et al.
Published: (2025)
by: Trine Hørmann Thomsen, et al.
Published: (2025)
Cinnamaldehyde Attenuates the Expression of IBA1 and GFAP to Inhibit Glial Cell Activation and Inflammation in the MPTP‐Induced Acute Parkinson’s Disease Model
by: Panpan Jiao, et al.
Published: (2024)
by: Panpan Jiao, et al.
Published: (2024)
Oxidative Stress: A New Pathophysiological Pathway in Parkinson’s Disease and a Potential Target of the Brain‐Sport Crosstalk
by: Stefano Caproni, et al.
Published: (2025)
by: Stefano Caproni, et al.
Published: (2025)
Association of Specific Leg Muscle Strength and Motor Features in Parkinson’s Disease
by: Chatkaew Pongmala, et al.
Published: (2024)
by: Chatkaew Pongmala, et al.
Published: (2024)
Cystatin C Secretion in Blood Derivatives and Cellular Models of Idiopathic Parkinson’s Disease
by: Kathleen Mommaerts, et al.
Published: (2025)
by: Kathleen Mommaerts, et al.
Published: (2025)
Genome‐Wide Association Studies Data and Transcriptomics Data Link Herpes Simplex Virus 1 Infection and Parkinson’s Disease
by: Changhao Lu, et al.
Published: (2025)
by: Changhao Lu, et al.
Published: (2025)
Improvement by Medication Less than Expected in Parkinson’s Disease: Blinded Evaluation of Levodopa Response
by: Mette Niemann Johansen, et al.
Published: (2024)
by: Mette Niemann Johansen, et al.
Published: (2024)
Alprazolam Reduces Freezing of Gait (FOG) and Improves FOG-Related Gait Deficiencies
by: Abdullah Al Jaja, et al.
Published: (2024)
by: Abdullah Al Jaja, et al.
Published: (2024)
Towards a Biologically Defined Diagnosis: Incorporating Pathophysiological Measures Into Parkinson’s Disease Clinical Criteria
by: Angus McNamara, et al.
Published: (2026)
by: Angus McNamara, et al.
Published: (2026)
Feasibility and Acceptability of Intervention and Trial Procedures of the UCL Live Well With Parkinson’s Self‐Management Toolkit
by: Tasmin Rookes, et al.
Published: (2025)
by: Tasmin Rookes, et al.
Published: (2025)
The Priority Goals and Underlying Impairments Contributing to Goal-Related Problems of People with Parkinson’s Disease Receiving a Community-Based Rehabilitation Program
by: Sarah J. Davies, et al.
Published: (2024)
by: Sarah J. Davies, et al.
Published: (2024)
Trait Impulsivity as a Feature of Parkinson’s Disease Treatment and Progression
by: Holly Spencer, et al.
Published: (2024)
by: Holly Spencer, et al.
Published: (2024)
Construction and Identification of Inflammation‐Related TF–mRNA–miRNA Coexpression Network and Immune Infiltration in Parkinson’s Disease
by: Zhuzhen Shen, et al.
Published: (2025)
by: Zhuzhen Shen, et al.
Published: (2025)
The Use of a Digital Social Forum in a Parkinson’s Disease Risk Cohort: A Thematic Analysis of Forum Messages
by: Laura J. Smith, et al.
Published: (2026)
by: Laura J. Smith, et al.
Published: (2026)
Clove Essential Oil Enhances Antioxidant Defenses and Reduces DNA Damage in a Cellular Model of Parkinson’s Disease
by: Dhouha Hamdi, et al.
Published: (2025)
by: Dhouha Hamdi, et al.
Published: (2025)
Mucuna pruriens Treatment for Parkinson Disease: A Systematic Review of Clinical Trials
by: Fatima Hammoud, et al.
Published: (2025)
by: Fatima Hammoud, et al.
Published: (2025)
Factors Influencing Pain Management Practices in People With Parkinson’s Disease: A Qualitative Descriptive Study
by: Anthony Mezzini, et al.
Published: (2025)
by: Anthony Mezzini, et al.
Published: (2025)
Focused Ultrasound Thalamotomy for Tremor Relief in Atypical Parkisnsonism
by: Alon Sinai, et al.
Published: (2024)
by: Alon Sinai, et al.
Published: (2024)
Mental Fatigue in Parkinson’s Disease: Systematic Review and Evaluation of Self‐Reported Fatigue Scales
by: Junle Chen, et al.
Published: (2024)
by: Junle Chen, et al.
Published: (2024)
Changes in Visual Evoked Potential and Optical Coherence Tomography in Parkinson’s Disease: A Systematic Review and Meta‐Analysis
by: Zahra Hemmatian, et al.
Published: (2025)
by: Zahra Hemmatian, et al.
Published: (2025)
Diagnostic Accuracy of Machine Learning‐Assisted MRI for Mild Cognitive Impairment in Parkinson’s Disease: A Systematic Review and Meta‐Analysis
by: Feng Zhang, et al.
Published: (2025)
by: Feng Zhang, et al.
Published: (2025)
Possible Implications of Managing Alexithymia on Quality of Life in Parkinson’s Disease: A Systematic Review
by: Laura Culicetto, et al.
Published: (2024)
by: Laura Culicetto, et al.
Published: (2024)
Research Participation Among American Indian and Alaskan Native Individuals Living With Parkinson’s Disease
by: Jacob D. Jones, et al.
Published: (2025)
by: Jacob D. Jones, et al.
Published: (2025)
A Cognitive‐Behavioral Model of Apathy in Parkinson’s Disease
by: Olivia Plant, et al.
Published: (2024)
by: Olivia Plant, et al.
Published: (2024)
Similar Items
-
Association between Subjective Cognitive Complaints and Incident Functional Impairment in Parkinson's Disease
by: Daniel Weintraub, et al.
Published: (2024) -
Determining Medication Adherence in Patients Treated for Parkinson’s Disease and Related Factors
by: Mahboobeh Besharatpour, et al.
Published: (2025) -
Predictive Value of Brain Volumetry in the Response to Subthalamotomy Using High‐Intensity Focused Ultrasound Treatment in Patients With Parkinson’s Disease
by: Alfaro-Nasta E., et al.
Published: (2025) -
Patient‐Reported Outcomes of Rotigotine in Parkinson’s Disease: Real‐World Evidence on Symptom Control and Quality of Life From China
by: Xiaodong Zhu, et al.
Published: (2025) -
Serum GDF‐15 Levels Correlate With Motor and Nonmotor Symptom Domains and Overall Disease Severity in Patients With Parkinson’s Disease
by: Noriyuki Miyaue, et al.
Published: (2026)